ROCHESTER, NY--(Marketwire - Dec 5, 2012) - NaturalNano, Inc. (OTCBB: NNAN) (www.naturalnano.com) announced that Fiabila has placed additional orders for NaturalNano's Halloysite Tube Technology (HNT). NaturalNano's HNT are environmentally friendly components that are incorporated into a range of the Fiabila produced nail polish products.
NaturalNano's CEO, James Wemett, said, "NaturalNano is very gratified with the continuing relationship with Fiabila and the commercial success shown to date in the Fiabila nail polish products that utilize our HNT. The current order is the result of market success for the range of Fiabila made products currently being sold at the largest retailers, including Target, Wal-Mart, CVS and Walgreens."
Wemett continued, "NaturalNano's relationship with Fiabila continues to represent an excellent long term revenue opportunity for us that utilizes our HNT™ to provide nail polishes with increased durability and performance. NaturalNano has an exclusive supply agreement and license with Fiabila for the use of HNT as a component in nail polish and nail-care products."
NaturalNano, Inc. (OTCBB: NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.